| Frontal fibrosing alopecia: a multicenter review of 355 patients S Vañó-Galván, AM Molina-Ruiz, C Serrano-Falcón, S Arias-Santiago, ... Journal of the American Academy of Dermatology 70 (4), 670-678, 2014 | 449 | 2014 |
| Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign” CG Wambier, S Vaño-Galván, J McCoy, A Gomez-Zubiaur, S Herrera, ... Journal of the American Academy of Dermatology 83 (2), 680-682, 2020 | 214 | 2020 |
| A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain-A potential clue to the role of androgens in COVID-19 severity A Goren, S Vano-Galvan, CG Wambier, J McCoy, A Gomez-Zubiaur, ... J Cosmet Dermatol 19 (7), 1545-1547, 2020 | 213 | 2020 |
| Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis I Alvarez‐Twose, S Vañó‐Galván, L Sánchez‐Muñoz, JM Morgado, ... Allergy 67 (6), 813-821, 2012 | 185 | 2012 |
| Androgen sensitivity gateway to COVID‐19 disease severity CG Wambier, A Goren, S Vaño‐Galván, PM Ramos, A Ossimetha, G Nau, ... Drug development research 81 (7), 771-776, 2020 | 175 | 2020 |
| Enanthem in patients with COVID-19 and skin rash J Jimenez-Cauhe, D Ortega-Quijano, D de Perosanz-Lobo, ... JAMA dermatology 156 (10), 1134-1136, 2020 | 109 | 2020 |
| Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential … J McCoy, CG Wambier, S Vano‐Galvan, J Shapiro, R Sinclair, PM Ramos, ... Journal of cosmetic dermatology 19 (7), 1542, 2020 | 107 | 2020 |
| SARS-CoV-2-induced telogen effluvium: a multicentric study. OM Moreno-Arrones, A Lobato-Berezo, A Gomez-Zubiaur, ... | 104 | 2020 |
| Folliculitis decalvans: a multicentre review of 82 patients S Vañó‐Galván, AM Molina‐Ruiz, P Fernández‐Crehuet, ... Journal of the European Academy of Dermatology and Venereology 29 (9), 1750-1757, 2015 | 103 | 2015 |
| Frontal fibrosing alopecia: clinical and prognostic classification OM Moreno‐Arrones, D Saceda‐Corralo, P Fonda‐Pascual, ... Journal of the European Academy of Dermatology and Venereology 31 (10), 1739 …, 2017 | 98 | 2017 |
| Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia J Jimenez-Cauhe, D Saceda-Corralo, R Rodrigues-Barata, ... Journal of the American Academy of Dermatology 81 (2), 648-649, 2019 | 96 | 2019 |
| Frequency of the types of alopecia at twenty-two specialist hair clinics: a multicenter study S Vañó-Galván, D Saceda-Corralo, U Blume-Peytavi, J Cucchía, ... Skin Appendage Disorders 5 (5), 309-315, 2019 | 95 | 2019 |
| Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02 C Tziotzios, C Petridis, N Dand, C Ainali, JR Saklatvala, V Pullabhatla, ... Nature communications 10 (1), 1150, 2019 | 93 | 2019 |
| Knowledge and perceptions of junior and senior Spanish resident doctors about antibiotic use and resistance: results of a multicenter survey C Navarro-San Francisco, MD Del Toro, J Cobo, JH De Gea-García, ... Enfermedades infecciosas y microbiologia clinica 31 (4), 199-204, 2013 | 93 | 2013 |
| Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients S Vañó-Galván, R Pirmez, A Hermosa-Gelbard, ÓM Moreno-Arrones, ... Journal of the American Academy of Dermatology 84 (6), 1644-1651, 2021 | 91 | 2021 |
| Dermoscopic features of skin lesions in patients with mastocytosis S Vano-Galvan, I án Álvarez-Twose, E De las Heras, JM Morgado, ... Archives of dermatology 147 (8), 932-940, 2011 | 91 | 2011 |
| What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy A Goren, J McCoy, CG Wambier, S Vano‐Galvan, J Shapiro, R Dhurat, ... Dermatologic therapy 33 (4), 2020 | 87 | 2020 |
| Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers OM Moreno‐Arrones, S Serrano‐Villar, V Perez‐Brocal, ... Journal of the European Academy of Dermatology and Venereology 34 (2), 400-405, 2020 | 82 | 2020 |
| Risk factors associated with frontal fibrosing alopecia: a multicentre case–control study OM Moreno‐Arrones, D Saceda‐Corralo, AR Rodrigues‐Barata, ... Clinical and Experimental Dermatology 44 (4), 404-410, 2019 | 80 | 2019 |
| Proxalutamide significantly accelerates viral clearance and reduces time to clinical remission in patients with mild to moderate COVID-19: results from a randomized, double … FA Cadegiani, J McCoy, CG Wambier, S Vaño-Galván, J Shapiro, A Tosti, ... Cureus 13 (2), 2021 | 76 | 2021 |
